Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders for MEDICINOVA INC, held on June 11, 2015. The filing covers corporate governance matters submitted to a vote by security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on voting results and does not contain financial performance data.
Material Changes
No material financial changes are reported in this filing. The document details the outcome of two specific shareholder proposals:
- Election of Director: Yuichi Iwaki, M.D., Ph.D., was elected as a Class II Director to serve until the 2018 Annual Meeting.
- Auditor Ratification: The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2015, was ratified.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the tabulation of votes cast at the annual meeting.
Important Facts for Investors
- Director Election Results: Yuichi Iwaki received 12,308,235 votes "For," 222,609 "Withheld," and 2,363,177 "Broker Non-Votes."
- Auditor Ratification Results: The proposal to ratify Ernst & Young LLP received 14,678,644 votes "For," 71,177 "Against," and 144,200 "Abstain."
- Meeting Date: The Annual Meeting took place on June 11, 2015.
- Reporting Date: The report was signed by the Chief Financial Officer on June 15, 2015.